MCP-6353: CLINICAL NUTRITION PRODUCTS – A GLOBAL STRATEGIC BUSINESS REPORT
March 8, 2017 - Imperative Need to Support Critical Nutritional Needs of Malnourished Patients, the Elderly and Infants to Spur Growth in the Global Clinical Nutrition Products Market, According to a New Report by Global Industry Analysts, Inc.
GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Clinical Nutrition Products market. The global market for Clinical Nutrition Products is projected to reach US$52.7 billion by 2022, driven by the growing need to provide nutritional support to the elderly and patients suffering from chronic medical conditions.
Clinical nutrition is one of the most critical areas of medicine and patient healthcare management. Clinical nutrition is vital for patients who are unable to consume normal food, as nutritional deficiency caused by underlying disease condition enhances the risk of complications, lengthens recovery period, lowers quality of life, and increases the risk of mortality among such patients. Comprising pharmaceutical-grade clinical foods and dietary supplements, clinical nutrition products are delivered through parenteral or enteral feeding routes, as a means to address issues such as eating disorders and metabolic disorders. Global market for clinical nutrition products is being driven by the increasing nutritional needs of an aging global population, rising incidence of chronic and lifestyle-related diseases, growing number of malnourished patients, increasing number of preterm births and the shift towards home care, all of which are driving emphasis onto the treatment of malnutrition in patients. In particular, the rising number of geriatric people with weak digestive systems implies that chronic diseases and loss of appetite are common issues confronting this age group, thus necessitating administration of clinical nutrition solutions. Demand for enteral and parenteral nutrition is also emerging due to the rapidly rising incidences of chronic and lifestyle-related diseases such as cancer, diabetes, cardiovascular diseases, gastrointestinal disorders and dementia across the world.
Infant nutrition products are used to assist development of infants, with the need for nutritional support highest among preterm infants. Since preterm babies suffer from immature organ development and lack of adequate immune response, they are unable to consume nutrition normally and nutrition being provided is inadequate, thus exposing the infants to higher risk of developing various health issues. The demand for safe, high quality and nutritive products for meeting the nutritional needs of premature infants, low-weight infants, and those afflicted by some medicals conditions is expected to fuel growth in the infant nutrition market over the coming years. Enteral nutrition products market continues to benefit from the development of disease-specific nutrient formulations. A large number of patients suffering from various medical conditions are given enteral nutrition therapies, owing to the advantages offered in the form of cost-effectiveness, safety and convenience of administration, and reduced discomfort. Parenteral nutrition, on the other hand, is being influenced by the adoption of stringent regulations, particularly in the U.S.
As stated by the new market research report on Clinical Nutrition Products, the United States represents the largest market worldwide. Rising cases of malnutrition among the elderly and those suffering from some form of chronic illness are propelling demand for clinical nutrition therapies. The market is also favored by the widespread availability of a broad variety of clinical nutrition solutions, high level of awareness about its benefits among patients and healthcare professionals and availability of reimbursement coverage. Asia-Pacific is forecast to grow at the fastest CAGR of 9.2% over the analysis period.
Major players covered in the report include Abbott Nutrition, Baxter International Inc., B. Braun Melsungen AG, Claris Lifesciences Ltd., Groupe Danone, Fresenius Kabi AG, ICU Medical Inc., Mead Johnson Nutrition Company, Meiji Co. Ltd., Nestlé Health Science S.A, Otsuka Pharmaceutical Factory Inc., and Huarui Pharmaceutical Co. Ltd. among others.
The research report titled “Clinical Nutrition Products: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (Australia, China, India and Rest of Asia-Pacific), Middle East & Africa and Latin America ((Brazil, Mexico and Rest of Latin America). The market is analyzed by the following product segments - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition.
Complimentary Market Brief:
Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used